Innate immune memory in cardiometabolic disease
H Bahrar, S Bekkering, R Stienstra… - Cardiovascular …, 2023 - academic.oup.com
Low-grade systemic inflammation is a key pathophysiological component of atherosclerotic
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
Innate immune memory in cardiometabolic disease.
H Bahrar, S Bekkering, R Stienstra… - Cardiovascular …, 2024 - europepmc.org
Low-grade systemic inflammation is a key pathophysiological component of atherosclerotic
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
Innate immune memory in cardiometabolic disease
H Bahrar, S Bekkering, R Stienstra, M Netea… - Cardiovascular …, 2024 - library.wur.nl
Low-grade systemic inflammation is a key pathophysiological component of atherosclerotic
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
[PDF][PDF] Innate immune memory in cardiometabolic disease
H Bahrar, S Bekkering, R Stienstra, MG Netea… - 2024 - repository.ubn.ru.nl
Low-grade systemic inflammation is a key pathophysiological component of atherosclerotic
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
Innate immune memory in cardiometabolic disease
B Harsh, B Siroon, S Rinke, N Mihai… - Cardiovascular Research, 2023 - agris.fao.org
Low-grade systemic inflammation is a key pathophysiological component of atherosclerotic
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
Innate immune memory in cardiometabolic disease
H Bahrar, S Bekkering, R Stienstra, M Netea… - Cardiovascular …, 2023 - research.wur.nl
Low-grade systemic inflammation is a key pathophysiological component of atherosclerotic
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
Innate immune memory in cardiometabolic disease
H Bahrar, S Bekkering, R Stienstra… - Cardiovascular … - pubmed.ncbi.nlm.nih.gov
Low-grade systemic inflammation is a key pathophysiological component of atherosclerotic
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
[HTML][HTML] Innate immune memory in cardiometabolic disease
H Bahrar, S Bekkering, R Stienstra… - Cardiovascular …, 2023 - ncbi.nlm.nih.gov
Low-grade systemic inflammation is a key pathophysiological component of atherosclerotic
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
[HTML][HTML] Innate immune memory in cardiometabolic disease
H Bahrar, S Bekkering, R Stienstra… - Cardiovascular …, 2023 - academic.oup.com
Low-grade systemic inflammation is a key pathophysiological component of atherosclerotic
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
Innate immune memory in cardiometabolic disease.
H Bahrar, S Bekkering, R Stienstra… - Cardiovascular …, 2023 - europepmc.org
Low-grade systemic inflammation is a key pathophysiological component of atherosclerotic
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …
cardiovascular disease (CVD), and long-term activation of myeloid cells is thought to be …